What Is a Nutraceutical? A Buyer's Guide to Definitions and Production

A nutraceutical is defined by its format as much as its ingredient. Hard-shell capsules suit powders and granules; softgels suit oils and lipid-soluble actives; tablets suit high-dose minerals and compressed blends. Each format has different tooling, fill tolerances, and minimum run lengths. A plant that runs all four can match the format to the ingredient rather than forcing the ingredient into a single line. EUPHM operates capsule, tablet, softgel, powder, and gummy lines under one roof in Guangdong.

Capacity matters when you scale. A single capsule line can fill 60,000–120,000 capsules per shift, depending on size and fill weight. Softgel lines run slower—typically 20,000–40,000 per shift—because of drying and curing steps. Powders and gummies have their own throughput curves. Knowing these numbers before you brief a manufacturer prevents the common mistake of promising a retail launch date that the line cannot meet.

A nutraceutical is only as good as its actives. Standardised botanical extracts, for example, specify a marker compound at a fixed percentage—curcumin at 95%, ashwagandha at 5% withanolides—so that every batch delivers the same dose. Vitamin and mineral premixes carry their own overage requirements to compensate for degradation over shelf life. Probiotic strains are defined by CFU count at end of shelf life, not at blending, which changes the overage strategy entirely.

Ingredient origin affects labelling and compliance. Organic claims require USDA organic or EU organic certification for the finished product, not just the raw material. Halal certifications apply to the gelatin capsule shell as well as the fill. Vegan capsules use HPMC or pullulan instead of bovine gelatin. For the Middle East and Southeast Asia, halal certification is often non-negotiable. These are formulation decisions, not afterthoughts—they change the bill of materials and the cost per unit.

Nutraceuticals are regulated differently from pharmaceuticals. In the US, they fall under DSHEA and require FDA-registered facility status, not FDA approval. In the EU, they are food supplements under Directive 2002/46/EC. The UK follows retained EU law with its own notification scheme. The Middle East varies by country: Saudi Arabia requires SFDA registration, the UAE requires MOHAP approval. A contract manufacturer must be able to supply the documentation each market demands—certificate of analysis, MSDS, flow chart, and declaration of conformity.

Logistics for nutraceuticals include temperature-sensitive probiotics and omega-3 liquids, which may need cold-chain or insulated shipping. Standard capsules and tablets ship at ambient. Customs classification depends on format and ingredient: most fall under HS 2106.90, but some vitamin preparations sit under HS 2936. Incorrect classification delays clearance. A manufacturer experienced in export documentation reduces that risk. EUPHM ships to the US, EU, UK, and Middle East with market-specific dossiers.

Every nutraceutical batch is tested at three stages: incoming raw materials, in-process, and finished goods. Raw material identity is confirmed by FTIR or HPLC against a reference standard, and potency is assayed to ensure the label claim can be met. Microbial testing covers total aerobic count, yeast and mould, E. coli, Salmonella, and Staphylococcus aureus. Heavy metals (lead, arsenic, cadmium, mercury) are screened against USP <232> or EU limits. Disintegration testing confirms capsules and tablets break down within the pharmacopoeial window, typically 30 minutes for capsules and 15 minutes for uncoated tablets.

A Certificate of Analysis (COA) is issued per batch and includes the product name, lot number, manufacturing date, expiry date, tests performed, specifications, results, and the analyst's signature. For export orders, the COA is often accompanied by a specification sheet and a statement of allergen status. Retention samples of each batch are kept for the shelf life plus six months, stored under label conditions. Stability protocols follow ICH Q1A(R2) guidelines, with accelerated testing at 40°C/75% RH for six months and real-time testing at 25°C/60% RH for the declared shelf life.

In-process checks include weight variation (target ±5% for capsules), hardness for tablets, and seal integrity for sachets. Environmental monitoring in the filling room tests air and surface samples for microbial counts monthly. Water used in production meets purified water standards and is tested for conductivity and microbial limits. Any out-of-specification result triggers a documented investigation before the batch is released. The complete batch record, including all test results, is retained for at least five years and is available to the brand owner on request.

Nutraceuticals can be packed in HDPE bottles (30–500 mL), blister packs (10–30 tablets per card), stick packs (2–10 g), or sachets (5–30 g). Bottles are fitted with induction seals and child-resistant closures where required. Labelling must include the statement of identity, net quantity, ingredient list, allergen declaration, and a supplement facts panel for the US market. For the EU, nutrition and health claims must comply with Regulation (EC) No 1924/2006. Lot codes and expiry dates are inkjet-printed on the base or crimp, and cartons carry the same information plus a barcode (UPC or EAN).

Carton specifications are agreed per order: typical dimensions are 60×60×120 mm for a 60-count bottle, with corrugated board grade B or C. Pallets are standard 1200×1000 mm or 1200×800 mm, stretch-wrapped and strapped, with a maximum height of 1.8 m for sea freight. For Amazon FBA, the factory can apply FNSKU labels, poly-bag units, and print the required expiration date in the format MM/DD/YYYY. Retail compliance checks include verifying that the label has no prohibited claims, that the supplement facts panel matches the formula, and that the barcode scans correctly.

Brand owners should supply print-ready artwork at 300 dpi with 3 mm bleed. The factory provides a digital proof and a physical pre-production sample for approval before mass printing. For small runs, digital printing is available at 1,000 labels per SKU; offset printing becomes cost-effective above 10,000 units. Packaging materials are stored in a controlled environment and are subject to incoming inspection for print quality and dimensional accuracy.

The MOQ for a new nutraceutical depends on the format. Capsules and tablets typically start at 1,000 units per SKU for retail bottling, while pilot runs from 500 units are possible for powders and gummies. Sample lead time is 7–10 working days after formula and packaging approval. Mass production takes 20–35 working days after sample approval and receipt of deposit, depending on raw material availability and packaging complexity. Orders above 50,000 units may require an additional 10–15 working days.

Shipping options include air freight (5–10 days door-to-door) and sea freight (25–40 days port-to-port). Incoterms offered are EXW, FOB (Shenzhen or Hong Kong), and DDP for select destinations. For DDP, the factory handles customs clearance and duties, but the brand owner must provide an importer of record or use the factory's appointed agent. Air freight is suitable for orders under 500 kg or time-sensitive launches; sea freight is more economical for full container loads (FCL) or less-than-container loads (LCL) above 1 cbm.

Documentation provided with each shipment includes the commercial invoice, packing list, bill of lading or airway bill, Certificate of Analysis, Material Safety Data Sheet (MSDS) where applicable, and a free-sale certificate for markets that require it. Phytosanitary certificates are provided for botanical ingredients upon request. The factory can also arrange third-party inspection (e.g., SGS, Bureau Veritas) at the brand owner's cost. All documents are issued in English and can be legalised or apostilled if needed.